Posted by: mevlux | July 6, 2009

British Journal of General Practice 2009 (Vol 59 No 564)

British Journal of General Practice 2009 (Vol 59 No 564) Contents Page

Fade Fave: Type 2 diabetes, thiazolidinediones, and cardiovascular risk

Fade Skinny: Achieving adequate glycaemic control is important in the therapy of type 2 diabetes. This article looks at the evidence behind any concerns and the most recent guidance on the use of thiazolidinediones in clinical practice.

(Print subscription held at Fade Library)


Leave a response

Your response:

Categories